Smith & Nephew plc
- SNN
- NYSE
- Medical devices
- Orthopaedic Implants
- Sports Medicine/ENT
- Wound Care
$28.84
Today −0.76%Quote Oct 19, 2026, 08:00 PM UTC
+4.61%over the last month
Max drawdown −4.9%From 1-month high −0.1%3 months −4.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
Sector
Healthcare
Industry
Medical devices
Exchange
NYSE
Employees
18,362
Founded
1856
Dividend date
Nov 6, 2026
Market value
$25.31B
Quote Oct 19
Floor
$28.25
2.0% below price
Resistance
$29.03
0.7% above price
Price vs analyst targets
23 analysts
Lowest target
$30.00Highest target
$33.88
$30.00Highest target
$33.88
- Price $28.84
- Average target $31.91
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 11% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SNNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free